Prostate Cancer: Epic Sciences AR-V7 Test

17 August 2017

OncLive

Insights From: Emmanuel S. Antonarakis, MBBCh, Johns Hopkins Medicine; Andrew J. Armstrong, MD, MSc, Duke Cancer Center; Howard I. Scher, MD, Memorial Sloan Kettering Cancer Center share their views on the Epic Sciences AR-V7 test in development for prostate cancer.

Source

Print

Shareholders

Read more

Pipeline

Read more

Media Center

Read more